EGFR and ocular toxoplasmosis: Blockade of EGFR led to spontaneous killing of T. gondii within endothelial cells, reduction in the foci of infected endothelial cells in vivo, decreased parasite load in the brain and retina as well as protection against cerebral and ocular toxoplasmosis.